Article info
PDFClinical ethics
Ethical allocation of future COVID-19 vaccines
- Correspondence to Rohit Gupta, Baylor College of Medicine, Houston, TX 77030-3411, USA; rohit.gupta{at}bcm.edu
Citation
Ethical allocation of future COVID-19 vaccines
Publication history
- Received August 26, 2020
- Revised December 7, 2020
- Accepted December 10, 2020
- First published December 17, 2020.
Online issue publication
February 22, 2021
Article Versions
- Previous version (17 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Justice in COVID-19 vaccine prioritisation: rethinking the approach
- Why we should not ‘ just use age ’ for COVID-19 vaccine prioritisation
- Allocation of COVID-19 vaccination: when public prioritisation preferences differ from official regulations
- Will vaccination refusal prolong the war on SARS - CoV-2
- Two centuries of immunisation in the UK (part II)
- Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK
- Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
- Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind
- Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
- Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time - series analysis